| | | | | 翰博高新材料（合肥）股份有限公司 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 编制单位：翰博高新材料（合肥）股份有限公 | | | | | | | | | 司 | | | | | | | | | 单位：万元 | | | | | | | | | | | 占用方与上市公司的关联 | | 上市公司核算的会计科 | | 2025年1-6月占用累计发生金 | 2025 | | 年1-6月占用资金 | 2025年1-6月偿还累计 | 2025年6月末占用 | | | | | | | 非经营性资金占用 | | 资金占用方名称 | | | 2025年初占用资金余 | | | | 额 | | | | 占用形成原因 | 占用性质 | | | | | | 关系 | 目 | | | 额(不含利息) 的利息(如有) | 发生 | | 金额 资金余额 | | | | | | | | | 控股股东、实际控制人及其附属企 业 | | | | | | | | | 小计 | — | — | | | | | | | — | - | - | - | - ...

Summary of Key Points Core Viewpoint - The documents provide detailed financial data regarding the accounts receivable and other financial interactions of Shandong Linuo Pharmaceutical Packaging Co., Ltd. with its related parties, highlighting significant amounts in both operating and non-operating transactions. Group 1: Accounts Receivable - The total accounts receivable from various related parties includes significant amounts such as 9.80 million from Shandong Hongjitang Pharmaceutical Group and 2.56 million from Hongjitang Bianque Chinese Medicine Pharmacy [1][2] - Other notable accounts receivable include 18.21 million from Linuo International Trade Co., Ltd. and 13.60 million from another related entity [2][3] - The company has a total of 240.25 million in accounts receivable, with a breakdown showing substantial amounts owed by various subsidiaries and related parties [3] Group 2: Financial Transactions - The documents indicate that there are non-operating fund usages amounting to significant figures, although specific amounts are not detailed in the provided text [1] - The financial interactions also include prepayments and other receivables, with 169.18 million noted for prepayments to a related gas company [3] - The total financial transactions involving related parties reflect a complex web of inter-company dealings, emphasizing the importance of monitoring these relationships for financial health [3]